Nuzenio

Tipranks Takeda Targets

Tipranks Takeda Targets news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Takeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study - TipRanksTipRanks · Fri, 07 Aug 2026 19:04:12 GMTTakeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1 - TipRanksTipRanks · Thu, 06 Aug 2026 01:23:12 GMTTakeda Earnings Call: FX Tailwinds, Pipeline Firepower - TipRanksTipRanks · Wed, 05 Aug 2026 00:55:05 GMTTakeda Advances Pediatric Pouchitis Trial, Extending Entyvio’s Long‑Term Growth Story - TipRanksTipRanks · Mon, 03 Aug 2026 22:00:40 GMTAnalysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD) - The Globe and MailThe Globe and Mail · Fri, 31 Jul 2026 17:06:00 GMTTakeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline - TipRanksTipRanks · Thu, 30 Jul 2026 10:19:15 GMTTakeda Targets Infection Risks in Older IBD Patients With New ENTYVIO Safety Study - TipRanksTipRanks · Mon, 27 Jul 2026 16:40:07 GMT

Timeline

Fri, 07 Aug 2026 19:04:12 GMTTakeda Targets High-Need Psoriasis Niche With New Phase 3b Zasocitinib Study - TipRanks
Thu, 06 Aug 2026 01:23:12 GMTTakeda Wins First-in-Class U.S. Approval for Orexin Therapy in Narcolepsy Type 1 - TipRanks
Wed, 05 Aug 2026 00:55:05 GMTTakeda Earnings Call: FX Tailwinds, Pipeline Firepower - TipRanks
Mon, 03 Aug 2026 22:00:40 GMTTakeda Advances Pediatric Pouchitis Trial, Extending Entyvio’s Long‑Term Growth Story - TipRanks
Fri, 31 Jul 2026 17:06:00 GMTAnalysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD) - The Globe and Mail
Thu, 30 Jul 2026 10:19:15 GMTTakeda Delivers Strong Q1 Revenue Growth But Flags Core EPS Decline - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Takeda Targets.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.